HHS committee to recommend lab test oversight

Share this article:
As DTC promoters push all kinds of genetic tests, a high-level HHS advisory committee is preparing to recommend that FDA should have some level of oversight for all lab tests, including the more than 1,100 genetic tests now offered by hundreds of labs across the nation. 
Share this article:

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.